|
Delayed
Hong Kong S.E.
04:08:27 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 14.07 HKD | +1.01% |
|
-7.13% | - |
Projected Income Statement: IMPACT Therapeutics, Inc
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| Net sales 1 | 264.8 | 629.6 | 692 |
| Change | - | 137.79% | 9.91% |
| EBITDA 1 | -140.7 | 121.4 | 63.66 |
| Change | - | 186.3% | -47.59% |
| EBIT 1 | -144.2 | 118.4 | 59.97 |
| Change | - | 182.11% | -49.36% |
| Interest Paid | - | - | - |
| Earnings before Tax (EBT) | - | - | - |
| Change | - | - | - |
| Net income | - | - | - |
| Change | - | - | - |
| Announcement Date | - | - | - |
1CNY in Million
Estimates
Forecast Balance Sheet: IMPACT Therapeutics, Inc
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| Net Debt 1 | -816 | -1,006 | -1,128 |
| Change | - | -23.28% | -12.13% |
| Announcement Date | - | - | - |
1CNY in Million
Estimates
Cash Flow Forecast: IMPACT Therapeutics, Inc
| Fiscal Period: December | 2024 | 2025 |
|---|---|---|
| CAPEX 1 | 1.695 | 1.51 |
| Change | - | -10.91% |
| Free Cash Flow (FCF) 1 | - | -136.6 |
| Change | - | - |
| Announcement Date | 5/5/26 | 5/5/26 |
1CNY in Million
Estimates
Forecast Financial Ratios: IMPACT Therapeutics, Inc
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
Profitability | ||||
| EBITDA Margin (%) | - | -53.15% | 19.29% | 9.2% |
| EBIT Margin (%) | - | -54.47% | 18.81% | 8.67% |
| EBT Margin (%) | - | - | - | - |
| Net margin (%) | - | - | - | - |
| FCF margin (%) | - | - | - | - |
| FCF / Net Income (%) | - | - | - | - |
Profitability | ||||
| ROA | -40.35% | - | - | - |
| ROE | 34.77% | - | - | - |
Financial Health | ||||
| Leverage (Debt/EBITDA) | - | - | - | - |
| Debt / Free cash flow | - | - | - | - |
Capital Intensity | ||||
| CAPEX / Current Assets (%) | - | - | - | - |
| CAPEX / EBITDA (%) | - | - | - | - |
| CAPEX / FCF (%) | - | - | - | - |
Items per share | ||||
| Cash flow per share 1 | - | - | - | - |
| Change | - | - | - | - |
| Dividend per Share 1 | - | - | - | - |
| Change | - | - | - | - |
| Book Value Per Share 1 | - | - | - | - |
| Change | - | - | - | - |
| EPS 1 | - | - | - | - |
| Change | - | - | - | - |
| Nbr of stocks (in thousands) | - | 282,462 | 282,462 | 282,462 |
| Announcement Date | - | - | - | - |
1CNY
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E | - | - |
| PBR | - | - |
| EV / Sales | 9.75x | 3.8x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
12.03CNY
Average target price
27.28CNY
Spread / Average Target
+126.79%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 7630 Stock
- Financials IMPACT Therapeutics, Inc
Select your edition
All financial news and data tailored to specific country editions
